Sage Journals: Discover world-class research

Abstract

Background

Phlegmasia Cerulae Dolen (PCD) is potentially a lethal disease but there is currently no established treatment algorithm for it. The aim of this study was to assess the safety and effectiveness of single stage endovascular pharmacomechanical thrombectomy with venoplasty and stenting in the treatment of PCD.

Method

This was a retrospective single centre observational study of consecutive patients who underwent endovascular intervention for the treatment of PCD between June 2016 and March 2020. Clinical and procedural details were recorded. Procedural and clinical success rate, procedural complications, and 30 days mortality were reported.

Result

11 patients were treated during the study period. 2 (18.2%) had active malignancy. 63.6% were uncomplicated PCD on presentation. Common iliac vein compression or stenosis were demonstrated in all patients. Venous stents were implanted in all cases and procedures were successful in all cases. All patients had symptoms improvement at 72 hours post procedure. Other than 2 major bleeding complications, there was no other adverse event. The 30 days mortality was 18.2%. Active malignancy and the presence of anaemia were significantly associated with major complications.

Conclusion

Single stage endovascular thrombectomy and stenting was effective and safe in the treatment of patients with PCD. Common Iliac vein compression was a common underlying cause of PCD.

Keywords

Phlegmasia venous thromboembolism mechanical thrombectomy May-Thurner syndrome

Get full access to this article

View all access options for this article.

References

Perkins

JMT

Magee

Galland

RB.

Phlegmasia caerulea dolens and venous gangrene. Br J Surg 1996; 83: 19–23.

Stallworth

Bradham

Kletke

, et al. Phlegmasia cerulea dolens: a 10-year review. Ann Surg 1965; 161: 802–811.

Weaver

Meacham

Adkins

, et al. Phlegmasia cerulea dolens: therapeutic considerations. South Med J 1988; 81: 306–312.

Chinsakchai

Ten Duis

Moll

, et al. Trends in management of phlegmasia cerulea dolens. Vasc Endovascular Surg 2011; 45: 5–14.

O’Connor

Lookstein

Endovascular interventions for venous disease. Tech Vasc Interv Radiol 2018; 21: 55–64.

Kahn

Partsch

Vedantham

, et al.; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7: 879–883.

Khalilzadeh

Baerlocher

Shyn

, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol 2017; 28: 1432–1437.

Chung

Yoon

Jung

, et al. Acute iliofemoral deep vein thrombosis: evaluation of underlying anatomic abnormalities by spiral CT venography. J Vasc Interv Radiol 2004; 15: 249–256.

Mewissen

Seabrook

Meissner

, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211: 39–49.

10.

Oguzkurt

Ozkan

Demirturk

, et al. Endovascular treatment of phlegmasia cerulea dolens with impending venous gangrene: manual aspiration thrombectomy as the first-line thrombus removal method. Cardiovasc Intervent Radiol 2011; 34: 1214–1221.

11.

Song

Liu

Zeng

, et al. The efficacy and safety of AngioJet rheolytic thrombectomy in the treatment of subacute deep venous thrombosis in lower extremity. Ann Vasc Surg 2019; 58: 295–301.

12.

Zhu

Liu

, et al. Single-stage treatment of AngioJet rheolytic thrombectomy and stenting for iliac vein compression syndrome with secondary acute iliofemoral deep vein thrombosis. Ann Vasc Surg 2019; 61: 384–393.

13.

Garcia

Lookstein

Malhotra

, et al. Endovascular management of deep vein thrombosis with rheolytic thrombectomy: final report of the prospective multicenter PEARL (peripheral use of AngioJet rheolytic thrombectomy with a variety of catheter lengths) registry. J Vasc Interv Radiol 2015; 26: 777–785.

14.

Aherne

Walsh

O’Sullivan

, et al. The ATTRACT trial may seem more attractive than it first looks for the management of acute deep vein thrombosis!. Phlebology 2019; 34: 221–223.

15.

Vedantham

Goldhaber

Julian

, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377: 2240–2252.

16.

O’Sullivan

Sheehan

Lohan

, et al. Iliofemoral venous stenting extending into the femoral region: initial clinical experience with the purpose-designed Zilver Vena stent. J Cardiovasc Surg (Torino) 2013; 54: 255–261.

17.

Razavi

Marston

Black

, et al. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord 2018; 6: 192–200.

18.

Raju

Buck

Crim

Jayaraj

Optimal sizing of iliac vein stents. Phlebology 2018; 33: 451–457.

19.

Weinberg

Kaufman

Jaff

MR.

Inferior vena cava filters. JACC Cardiovasc Interv 2013; 6: 539–547.

20.

Kwon

Park

, et al. Prophylactic placement of an inferior vena cava filter during aspiration thrombectomy for acute deep venous thrombosis of the lower extremity. Vasc Endovascular Surg 2016; 50: 270–276.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

A new treatment paradigm for phlegmasia cerulea dolen: Single stage endovascular pharmacomechanical thrombectomy with venoplasty and stenting